ftInvstr
ALBERTDAVD · Healthcare ₹804.0 +1.28% Mkt Cap ₹462 Cr

ALBERTDAVD

Healthcare Drug Manufacturers - Specialty & Generic
₹804.0
+1.28% today · 30d +1.89%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for ALBERTDAVD. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹101 Cr
+43.6% YoY
NET PROFIT
₹32 Cr
+303.12% YoY
OPM
29.85%
+17.56pp YoY
EPS
₹56.07
PE 20.68
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
ALBERTDAVD20.68—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
59
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation REASONABLE 60
Growth DECLINING 29
Profitability HIGH 90
Technicals NEUTRAL 55
Risk LOW 80
Key Stats
TTM PE
20.68
P/B
1.19
52W HIGH
₹931.85
OFF HIGH
-13.72%
DIV YIELD
0.62%
MKT CAP
₹462 Cr
◉ Active Signals
MACDNeutral4.9302
RSI(14)Neutral53.79
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ALBERTDAVD and at what entry.

Sign up freeSign in